Synovo's main pharmacology activities are based on assays and models for the selection of drug candidates with improved properties of Absorbtion, Disposition, Metabolism and Elimination (ADME or DMPK). Synovo establishes these parameters using human derived cells, proteins and systems wherever feasible to ensure the relevance of its data to use in man. Synovo is engaged in projects in the fields of anti-inflammatory and immune suppressive drug optimisation on behalf of clients from the pharmac...